Loading the content... Loading depends on your connection speed!

Enter New Email
Confirm New Email
Enter Old Password
Enter New Password
Confirm New Password
 
Email sent successfully to:
Algorithm Information

Risk Factors for Bleeding During Antithrombotic Therapy from the NICE Guidelines for Atrial Fibrillation

MyLikes

MyPaths
Purpose:
To identify risk factors for bleeding in a patient taking oral anticoagulant therapy for atrial fibrillation based on the NICE guidelines.
Specialty
  • Hematology Oncology
    Clinical Laboratory
    Pharmacology
  • Clinical
Objective
  • Risk factors
  • Severity
  • Prognosis
  • Stage
ICD-10
  • I48

In order to access the algorithms, please subscribe to a plan that fits your needs.

MyPaths
Cancel
Create Path
Create
Cancel
Create Note
Save
Risk Factors for Bleeding During Antithrombotic Therapy from the NICE Guidelines for Atrial Fibrillation
Cancel
Save Data
Save
Limitation to 5 characters is for patient privacy.